The economic burden of constipation therapy

Authors

  • Anamaria Albu
  • Andreea Farcas
  • Liliana David
  • Dan L. Dumitrascu

DOI:

https://doi.org/10.15386/mpr-1222

Keywords:

constipation, drug, health economics, pharmaeconomics

Abstract

Background and aim. Constipation is a widespread condition that requires adequate therapy. Given the large use of laxatives, it is important to know the burden of the treatment of this condition on the healthcare budget.

Methods. We collected information on the number of therapeutic units (boxes) of five frequently used laxatives delivered by prescription or over the counter in 30 pharmacies randomly selected in two adjacent counties from Romania for two consecutive years. We calculated also the cost value of the laxatives delivered.

Results. The total cost of laxatives in the group of pharmacies investigated was on average 62,500 euros per year. We extrapolated that the laxative consumption in Romania should be over 15 million Euro.

Conclusions. To our knowledge this is the first study on the burden of constipation in this country. Although therapeutic units of laxatives are not expensive, the wide use of these drugs represents an economic burden for the patient.

Author Biographies

Anamaria Albu, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca

2nd Dept of Internal Medicine

Andreea Farcas, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca

Drug Information Research Center

Liliana David, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca

2nd Dept of Internal Medicine

Dan L. Dumitrascu, Iuliu Hatieganu University of Medicine and Pharmacy Cluj-Napoca

2nd Dept of Internal Medicine

Downloads

Published

2019-05-23

How to Cite

1.
Albu A, Farcas A, David L, Dumitrascu DL. The economic burden of constipation therapy. Med Pharm Rep [Internet]. 2019 May 23 [cited 2025 Sep. 26];92(3):261-4. Available from: https://medpharmareports.com/index.php/mpr/article/view/1222

Issue

Section

Original Research